Literature DB >> 11095866

Staphylococcus aureus Endocarditis in the 21st Century.

.   

Abstract

Entities:  

Year:  2000        PMID： 11095866     DOI： 10.1007/s11908-000-0004-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  8 in total

1.  Glycopeptide Resistance in Staphylococcus aureus.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia.

Authors:  I Raad; F Bompart; R Hachem
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

3.  In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

Authors:  R Patel; M S Rouse; K E Piper; J M Steckelberg
Journal:  Diagn Microbiol Infect Dis       Date:  1999-06       Impact factor: 2.803

4.  Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia.

Authors:  A B Rosen; V G Fowler; G R Corey; S M Downs; A K Biddle; J Li; J G Jollis
Journal:  Ann Intern Med       Date:  1999-05-18       Impact factor: 25.391

5.  Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark.

Authors:  B L Røder; D A Wandall; N Frimodt-Møller; F Espersen; P Skinhøj; V T Rosdahl
Journal:  Arch Intern Med       Date:  1999-03-08

6.  Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.

Authors:  V G Fowler; L L Sanders; L K Kong; R S McClelland; G S Gottlieb; J Li; T Ryan; D J Sexton; G Roussakis; L J Harrell; G R Corey
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

7.  Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin.

Authors:  M A Cohen; M D Huband
Journal:  Diagn Microbiol Infect Dis       Date:  1999-01       Impact factor: 2.803

8.  Native valve staphylococcal endocarditis: etiology, risk factors and outcome in 53 cases.

Authors:  V Hricak; F Matejicka; T Sedlák; I Duris; V Milovský; J Kovacik; P Marks; D West; V Krcméry
Journal:  J Chemother       Date:  1998-10       Impact factor: 1.714
  8 in total
  1 in total

1.  Purulent Meningitis as an Unusual Presentation of Staphylococcus aureus Endocarditis: A Case Report and Literature Review.

Authors:  Giancarlo Ceccarelli; Gabriella d'Ettorre; Vincenzo Vullo
Journal:  Case Rep Med       Date:  2011-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.